Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001493152-25-006091
Filing Date
2025-02-12
Accepted
2025-02-12 14:10:38
Documents
6

Document Format Files

Seq Description Document Type Size
1 form424b5.htm 424B5 730740
2 form424b5_001.jpg GRAPHIC 4013
3 form424b5_002.jpg GRAPHIC 12965
4 form424b5_003.jpg GRAPHIC 18841
5 form424b5_004.jpg GRAPHIC 20347
6 form424b5_005.jpg GRAPHIC 20194
  Complete submission text file 0001493152-25-006091.txt   837620
Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001335105 (see all company filings)

EIN.: 202903526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-278874 | Film No.: 25614075
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)